A detailed history of Tower Research Capital LLC (Trc) transactions in Artivion, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,738 shares of AORT stock, worth $105,673. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,738
Previous 6,939 46.13%
Holding current value
$105,673
Previous $177,000 44.07%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$24.33 - $28.46 $77,880 - $91,100
-3,201 Reduced 46.13%
3,738 $99,000
Q2 2024

Aug 13, 2024

BUY
$19.62 - $25.65 $73,496 - $96,084
3,746 Added 117.32%
6,939 $177,000
Q1 2024

May 15, 2024

SELL
$16.7 - $21.63 $158,382 - $205,138
-9,484 Reduced 74.81%
3,193 $67,000
Q4 2023

Feb 13, 2024

BUY
$12.33 - $18.83 $78,307 - $119,589
6,351 Added 100.4%
12,677 $226,000
Q3 2023

Nov 14, 2023

BUY
$14.82 - $17.52 $68,898 - $81,450
4,649 Added 277.22%
6,326 $95,000
Q2 2023

Aug 14, 2023

BUY
$12.78 - $17.23 $10,108 - $13,628
791 Added 89.28%
1,677 $28,000
Q1 2023

May 09, 2023

SELL
$11.74 - $14.12 $57,502 - $69,159
-4,898 Reduced 84.68%
886 $12,000
Q4 2022

Feb 10, 2023

SELL
$10.01 - $13.9 $3,363 - $4,670
-336 Reduced 5.49%
5,784 $70,000
Q3 2022

Nov 10, 2022

BUY
$13.31 - $23.25 $57,286 - $100,068
4,304 Added 237.0%
6,120 $84,000
Q2 2022

Aug 15, 2022

BUY
$15.73 - $22.91 $23,689 - $34,502
1,506 Added 485.81%
1,816 $34,000
Q1 2022

May 12, 2022

SELL
$16.95 - $21.74 $78,427 - $100,590
-4,627 Reduced 93.72%
310 $7,000
Q4 2021

Feb 14, 2022

BUY
$17.19 - $22.84 $67,900 - $90,218
3,950 Added 400.2%
4,937 $100,000
Q3 2021

Nov 15, 2021

SELL
$22.29 - $28.7 $23,181 - $29,848
-1,040 Reduced 51.31%
987 $22,000
Q2 2021

Aug 16, 2021

SELL
$22.32 - $32.07 $207,107 - $297,577
-9,279 Reduced 82.07%
2,027 $58,000
Q1 2021

May 17, 2021

BUY
$22.07 - $26.31 $12,292 - $14,654
557 Added 5.18%
11,306 $255,000
Q4 2020

Feb 16, 2021

SELL
$16.76 - $23.74 $547,549 - $775,585
-32,670 Reduced 75.24%
10,749 $253,000
Q3 2020

Nov 16, 2020

BUY
$16.35 - $21.4 $565,301 - $739,905
34,575 Added 390.94%
43,419 $802,000
Q2 2020

Aug 13, 2020

BUY
$16.34 - $25.24 $118,301 - $182,737
7,240 Added 451.37%
8,844 $170,000
Q1 2020

May 15, 2020

BUY
$14.66 - $30.57 $23,514 - $49,034
1,604 New
1,604 $27,000
Q4 2019

Feb 07, 2020

SELL
$22.45 - $27.09 $51,298 - $61,900
-2,285 Closed
0 $0
Q3 2019

Nov 05, 2019

BUY
$25.98 - $30.8 $46,374 - $54,978
1,785 Added 357.0%
2,285 $62,000
Q2 2019

Aug 13, 2019

BUY
$27.55 - $32.39 $13,775 - $16,195
500 New
500 $15,000
Q1 2018

May 15, 2018

SELL
$16.85 - $22.1 $39,176 - $51,382
-2,325 Closed
0 $0
Q4 2017

Feb 09, 2018

SELL
$18.65 - $23.85 $447 - $572
-24 Reduced 1.02%
2,325 $45,000
Q3 2017

Nov 14, 2017

BUY
$18.85 - $23.05 $44,278 - $54,144
2,349
2,349 $53,000

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.14B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.